Oral administration form for peptide pharmaceutical substances, in particular insulin

摘要

PCT No. PCT/DE92/01009 Sec. 371 Date Sep. 13, 1994 Sec. 102(e) Date Sep. 13, 1994 PCT Filed Dec. 4, 1992 PCT Pub. No. WO93/10767 PCT Pub. Date Jun. 10, 1993A peroral administration form for peptidic medicaments contains the peptidic medicament, in particular insulin, distributed in a gelatine or gelatine derivate matrix, besides usual pharmaceutical excipients and additives. By selecting an appropriate gelatine, the medicament is released in the small or large intestine, so that it is no longer enzymatically decomposed by peptidases.